Physician profile
Aroosa Malik
NPI 1629694054
$891.02
in general payments reported to CMS, 2019-2025
15 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $686 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $188.46 | 2024-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $118.92 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $89.12 | 2024-2025 | Onpattro |
| Atricure, INC. | $87.11 | 2024-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Abbott Laboratories | $66.74 | 2024 | Assurity, Merlin@Home, Diamondback Coronary |
| Astrazeneca Pharmaceuticals LP | $62.13 | 2024 | Wainua, Farxiga |
| Abiomed | $54.32 | 2024 | Impella |
| Bridgebio Pharma, INC. | $50.83 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $37.44 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $34.53 | 2024 | |
| Medtronic, INC. | $28.28 | 2024 | Azure Xt Dr Mri Surescan |
| Chiesi USA, INC. | $23.02 | 2024 | Cleviprex, Kengreal |
| Bayer Healthcare Pharmaceuticals INC. | $20.14 | 2025 | |
| Pfizer INC. | $16.05 | 2025 | |
| Lantheus Medical Imaging, INC. | $13.93 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aroosa Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.